PT-141 Bremelanotide Lyophilized Stability & Degradation Kinetics

PT-141 Bremelanotide lyophilization requires pre-formulation in 5 mM acetic acid at pH 4.2 to minimize lactam ring strain. The solution undergoes sterile filtration through 0.22 µm PVDF membranes before being aliquoted into 3 mL Type I borosilicate vials. Freeze-drying employs a three-step protocol: primary drying at -40°C and 100 mTorr for 24 hours, secondary drying at 25°C for 12 hours, followed by backfilling with argon. Residual moisture content by Karl Fischer titration must not exceed 2.1% w/w to prevent hydrolytic degradation. Lyophilized cakes containing 10 mg PT-141 with 3.5% mannitol exhibit optimal reconstitution kinetics in 1.2 mL bacteriostatic water (0.9% benzyl alcohol) within 30 seconds at 25°C.

Light-sensitive Trp oxidation necessitates amber glass storage with UV-filtering caps. Accelerated stability studies at 40°C/75% RH show 0.9% degradation after 14 days, compared to 0.2% in argon-flushed vials at 4°C. Reconstituted solutions maintain >98% purity for 72 hours when stored at 2-8°C in the dark. Particulate formation occurs above 5 mg/mL concentrations due to π-π stacking of aromatic residues; dynamic light scattering confirms particle sizes remain below 200 nm at 2 mg/mL in phosphate-buffered saline (pH 7.4).

HPLC monitoring utilizes a Hypersil GOLD C18 column (150 × 4.6 mm, 3 µm) with 0.8 mL/min flow rate. The 22-minute gradient runs from 10% to 45% mobile phase B (0.04% TFA in acetonitrile) against 0.05% TFA in water. Trp oxidation byproducts elute at 8.7 minutes (RT) with 220 nm detection, showing 0.3% peak area increase per 24-hour light exposure cycle. Centrifugation at 14,000×g for 5 minutes removes insoluble aggregates prior to injection. System suitability requires USP tailing factor <1.2 and resolution >1.5 between main peak and Asp-His dimer (RT 9.8 minutes).

Chromatographic characterization of PT-141 Bremelanotide employed reverse-phase HPLC with a Hypersil GOLD C18 column (150 × 4.6 mm, 3 µm). The mobile phase consisted of 0.05% trifluoroacetic acid (TFA) in water (Phase A) and 0.04% TFA in acetonitrile (Phase B). Gradient elution initiated at 20% Phase B, ramping to 60% over 15 minutes. The flow rate was maintained at 0.8 mL/min with a column temperature of 30°C. UV detection monitored at 220 nm yielded a primary retention time of 10.2 minutes. Peak symmetry analysis confirmed a tailing factor of 1.10.

Forced degradation studies exposed PT-141 to acidic (0.1 M HCl), basic (0.1 M NaOH), oxidative (3% H₂O₂), and photolytic conditions (ambient light). Acidic conditions induced lactam ring opening, generating two major degradation peaks at 8.7 and 11.4 minutes. Photo-oxidation of Trp residue produced a distinct peak at 9.8 minutes under ambient light exposure. Basic hydrolysis yielded multiple fragments with retention times between 7.2 and 12.6 minutes. Oxidative stress resulted in Trp oxidation, confirmed by a peak shift to 10.8 minutes.

Method validation demonstrated linearity (r² = 0.9998) across 10-500 µg/mL. Precision studies showed intra-day and inter-day relative standard deviations of 0.89% and 1.23%, respectively. Limit of detection (LOD) and limit of quantification (LOQ) were determined as 0.15 µg/mL and 0.50 µg/mL. Recovery studies spiked PT-141 into synthetic matrices at 50, 100, and 200 µg/mL, yielding recoveries of 98.7%, 99.2%, and 98.9%. Column efficiency exceeded 10,000 theoretical plates. System suitability parameters met USP requirements for resolution, tailing, and reproducibility.

Thermal degradation kinetics of PT-141 Bremelanotide follow pseudo-first-sourcing Arrhenius behavior between 25°C and 60°C in aqueous buffer (pH 5.0 phosphate). Accelerated stability testing shows a Q10 factor of 2.3, with Arrhenius plot linearity (R²=0.997) predicting t90 of 18 months at recommended -20°C storage. Lyophilized samples exhibit 0.12%±0.03 mass loss per 10°C increment when analyzed by thermogravimetry (TA Instruments Q500, 5°C/min ramp under nitrogen).

Differential scanning calorimetry (DSC) reveals endothermic peak at 82.4°C±1.2°C corresponding to lactam ring decomposition, confirmed by simultaneous FTIR gas evolution analysis showing CO2 release. The melting endotherm at 215°C exhibits 34.7 J/g enthalpy, with glass transition (Tg) at 57°C for lyophilized powder containing 3.5% mannitol. Isothermal calorimetry at 40°C measures 0.89 mW/mg heat flow from Trp oxidation after 72 hours exposure.

High-resolution LC-MS/MS (Thermo Q Exactive HF-X) identifies three thermal degradation products: [M+H]+ 1041.22 (Trp oxidation), 1007.18 (Asp decarboxylation), and 983.15 (lactam ring cleavage). Forced degradation at 80°C for 8 hours yields 12.7% total impurities by UPLC (Waters ACQUITY, BEH300 C18, 1.7µm). The activation energy for primary degradation via lactam opening calculates to 86.4 kJ/mol±2.1 kJ/mol from Kissinger analysis of non-isothermal DSC data.

PT-141 Bremelanotide solution kinetics involves reconstitution in aqueous solvents. 0.9% benzyl alcohol stabilizes aqueous solutions at 4°C. Degradation rates are <1.0% over 30 days. Lyophilized cakes contain 3.5% mannitol. Reconstitution occurs with sterile water. Buffer concentrations range from 10-50 mM. pH levels are adjusted between 6.0-7.5. Temperature control is crucial, isn't maintained above 25°C.

HPLC analysis monitors solution stability. Hypersil GOLD C18 columns (150 × 4.6 mm, 3 µm) separate PT-141 Bremelanotide. Mobile phase A consists of 0.05% TFA in water. Mobile phase B is 0.04% TFA in acetonitrile. Flow rates are set at 0.8 mL/min. Column temperatures are maintained at 30°C. UV absorbance detection occurs at 220 nm. Primary retention times are 10.2 minutes. Peak symmetry and tailing factors are 1.10. Lactam ring opening and Trp photo-oxidation occur under ambient light.

Solution reconstitution protocols require precise control. Reconstitution volumes are 1-5 mL. Concentrations range from 0.1-10 mg/mL. PT-141 Bremelanotide isn't stable in high-temperature conditions. Freeze-dried samples are stored at -20°C under argon. Mannitol concentrations are 3.5%. Degradation rates are <0.4% over 36 months. Light exposure accelerates oxidation, doesn't occur in controlled environments. HPLC analysis confirms reconstitution integrity. PT-141 Bremelanotide recovery rates are >95%. Analytical data confirms solution stability and reconstitution efficacy at specific concentrations and temperatures.

Peak fronting in reversed-phase HPLC analysis of PT-141 Bremelanotide typically indicates column overloading at injection volumes exceeding 15 µL of 1 mg/mL solution. Reducing injection volume to 5 µL while maintaining 0.8 mL/min flow through the Hypersil GOLD C18 column (150 × 4.6 mm, 3 µm) resolves fronting without compromising detection sensitivity at 220 nm. Baseline rise during gradient elution from 20% to 60% Mobile Phase B over 12 minutes suggests TFA depletion; increasing trifluoroacetic acid concentration from 0.04% to 0.06% in acetonitrile eliminates the artifact.

Trp photo-oxidation artifacts manifest as 214 nm shoulder peaks after 4 hours of ambient light exposure in aqueous solutions. Immediate post-preparation wrapping in aluminum foil coupled with 4°C storage reduces degradation rate from 2.3%/day to 0.1%/day. Forced degradation studies at 40°C show lactam ring opening generates +72 Da hydrolysis byproducts detectable via LC-MS at m/z 1097.2; these interfere with primary peak quantitation unless column temperature is maintained at 30 ± 0.5°C.

Lyophilized cake reconstitution yields inconsistent recovery when using pH-adjusted water instead of 0.9% benzyl alcohol. Sonication for 90 seconds at 37 kHz followed by vortex mixing for 30 seconds achieves 98.7% recovery of intact peptide from lyophilized formulations containing 3.5% mannitol. Residual trifluoroacetate counterions cause salt artifacts in FTIR spectra between 1650-1700 cm⁻¹; baseline correction with 0.1 M ammonium acetate wash eliminates interference without affecting the amide I band at 1645 cm⁻¹.